Ishioh M, Nozu T, Okumura T. Brain neuropeptides, neuroinflammation, and irritable bowel syndrome. Digestion. 2024;105:34–9.
Article CAS PubMed Google Scholar
Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014;20:6759–73.
Article PubMed PubMed Central Google Scholar
Azarfarin M, Moradikor N, Matin S, Dadkhah M. Association between stress, neuroinflammation, and irritable bowel syndrome: the positive effects of probiotic therapy. Cell Biochem Funct. 2024;42:e70009.
Article CAS PubMed Google Scholar
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37.
Article CAS PubMed PubMed Central Google Scholar
Wang JG, Zhang W, Li Y, Liu L. Hypertension in China: epidemiology and treatment initiatives. Nat Rev Cardiol. 2023;20:531–45.
Gupta H, Vidhale T, Pustake M, Gandhi C, Roy T. Utility of ambulatory blood pressure monitoring in detection of masked hypertension and risk of hypertension mediated organ damage in normotensive patients with type 2 diabetes mellitus. Blood Press. 2022;31:50–7.
Article CAS PubMed Google Scholar
Thakkar HV, Pope A, Anpalahan M. Masked hypertension: a systematic review. Heart Lung Circ. 2020;29:102–11.
Kaul U, Wander G, Sinha N, et al. Self-blood pressure measurement as compared to office blood pressure measurement in a large Indian population; the India Heart Study. J Hypertens. 2020;38:1262–70.
Marwaha K. Examining the role of psychosocial stressors in hypertension. J Prev Med Pub Health. 2022;55:499.
Hall JE, Omoto AC, Wang Z, Mouton A, Li X, Hall ME. Pathophysiology of hypertension. In: Hypertension. Elsevier; 2024. p. 71–86.
Ushakov AV, Ivanchenko VS, Gagarina AA. Psychological stress in pathogenesis of essential hypertension. Curr Hypertens Rev. 2016;12:203–14.
Undseth R, Berstad A, Valeur J. Systemic symptoms in irritable bowel syndrome: an investigative study on the role of enterocyte disintegrity, endotoxemia and inflammation. Mol Med Rep. 2016;14:5072–6.
Article CAS PubMed PubMed Central Google Scholar
Nakov R, Snegarova V, Dimitrova-Yurukova D, Velikova T. Biomarkers in irritable bowel syndrome: biological rationale and diagnostic value. Dig Dis. 2022;40:23–32.
Zhou J, Zhang H, Huo P, et al. The association between circulating short-chain fatty acids and blood pressure in Chinese elderly population. Sci Rep. 2024;14:27062.
Article CAS PubMed PubMed Central Google Scholar
De la Cuesta-Zuluaga J, Mueller NT, Álvarez-Quintero R, et al. Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors. Nutrients. 2018;11:51.
Article PubMed PubMed Central Google Scholar
Shaikh SD, Sun N, Canakis A, Park WY, Weber HC. Irritable bowel syndrome and the gut microbiome: a comprehensive review. J Clin Med. 2023;12:2558.
Article CAS PubMed PubMed Central Google Scholar
Cui Y, Dong J, Du X, et al. Comparison of prognosis and outcomes of catheter ablation versus drug therapy in patients with atrial fibrillation and stable coronary artery disease: a prospective propensity-score matched cohort study. Clin Cardiol. 2021;44:1422–31.
Article PubMed PubMed Central Google Scholar
Suresh MG, Mohamed S, Yukselen Z, et al. Therapeutic modulation of gut microbiome in cardiovascular disease: a literature review. Heart Mind. 2025;9:68–79.
Duan R, Zhu S, Wang B, Duan L. Alterations of gut microbiota in patients with irritable bowel syndrome based on 16S rRNA-targeted sequencing: a systematic review. Clin Transl Gastroenterol. 2019;10:e00012.
Article PubMed PubMed Central Google Scholar
Kyriakoulis KG, Kollias A, Stergiou GS. Masked hypertension: how not to miss an even more silent killer. Hypertens Res. 2023;46:778–80.
Anstey DE, Moise N, Kronish I, Abdalla M. Masked hypertension: whom and how to screen? Curr Hypertens Rep. 2019;21:1–4.
Shah SN, Munjal Y, Kamath SA, et al. Indian guidelines on hypertension-IV (2019). J Hum Hypertens. 2020;34:745–58.
Yıldız G, Söğüt G. Masked hypertension in patients with irritable bowel syndrome. Indian J Gastroenterol. 2025. https://doi.org/10.1007/s12664-025-01745-z.
Dean YE, LoayzaPintado JJ, Rouzan SS, et al. The relationship between irritable bowel syndrome and metabolic syndrome: a systematic review and meta-analysis of 49,662 individuals. Endocrinol Diabetes Metab. 2025;8:e70041.
Article CAS PubMed PubMed Central Google Scholar
Davydov DM, Naliboff B, Shahabi L, Shapiro D. Baroreflex mechanisms in irritable bowel syndrome: Part I. Traditional indices Physiol Behav. 2016;157:102–8.
Article CAS PubMed Google Scholar
Phillips K, Wright BJ, Kent S. Irritable bowel syndrome and symptom severity: evidence of negative attention bias, diminished vigour, and autonomic dysregulation. J Psychosom Res. 2014;77:13–9.
Staller K, Olén O, Söderling J, et al. Mortality risk in irritable bowel syndrome: results from a nationwide prospective cohort study. Am J Gastroenterol. 2020;115:746–55.
Article PubMed PubMed Central Google Scholar
Seeling KS, Hehl L, Vell MS, et al. Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: a phenome-wide association study. United Eur Gastroenterol J. 2023;11:458–70.
Judkins CP, Wang Y, Jelinic M, et al. Association of constipation with increased risk of hypertension and cardiovascular events in elderly Australian patients. Sci Rep. 2023;13:10943.
Article CAS PubMed PubMed Central Google Scholar
Zheng T, Camargo Tavares L, D’Amato M, Marques FZ. Constipation is associated with an increased risk of major adverse cardiac events in a UK population. Am J Physiol-Heart Circ Physiol. 2024;327:H956–64.
Article CAS PubMed Google Scholar
Soltani S, Keshteli AH, Esmaillzadeh A, Adibi P. Adherence to dietary approaches to stop hypertension eating plan and prevalence of irritable bowel syndrome in adults. J Neurogastroenterol Motil. 2021;27:78–86.
Comments (0)